Sale!

CLN6 Additional Family Members Test Cost

Original price was: 4,000 د.إ.Current price is: 2,600 د.إ.

-35%

The “CLN6 Additional Family Members Test” is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations in the CLN6 gene, which are associated with certain neurodegenerative disorders, including a form of Batten disease. This test is particularly important for families with a known history of such conditions, as it helps in understanding the genetic risk for other family members. The test is priced at 2600 AED and is conducted with high precision in the state-of-the-art facilities of DNA Labs UAE. By analyzing specific genetic markers, the test provides crucial information that can guide clinical management and inform about potential treatments or interventions. This test is a valuable resource for families seeking to assess the genetic health landscape of their members, especially in the context of inherited neurological conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLN6 Additional Family Members Test

Test Cost: AED 2600.0

Symptoms and Diagnosis

CLN6 is a gene associated with the rare genetic disorder, Ceroid Lipofuscinosis, Neuronal 6. This disorder primarily affects the nervous system and can lead to a range of symptoms including vision loss, seizures, movement difficulties, and cognitive decline.

Test Details

When it comes to additional family members, it is important to consider the inheritance pattern of CLN6. This disorder is typically inherited in an autosomal recessive manner, meaning that both parents must carry a mutated copy of the CLN6 gene for their child to be affected. If a person has CLN6 and they have siblings, there is a chance that their siblings could also be carriers of the mutated gene.

If both parents are carriers, each sibling would have a 25% chance of being affected by CLN6, a 50% chance of being a carrier, and a 25% chance of not having the mutated gene at all.

Pre Test Information

It is recommended that family members of an individual with CLN6 consult with a genetic counselor or healthcare provider to understand their own risk and the potential implications for future family planning.

Test Type and Components

  • Test Name: CLN6 Additional Family Members Test
  • Components: Blood Sample
  • Price: AED 2600.0
  • Report Delivery Method: Doctor
  • Test Department: Genetic Testing

Conclusion

Genetic testing can be performed to determine if someone is a carrier of the CLN6 mutation. This information can help individuals make informed decisions about their future family planning.

Test Name CLN6 Additional Family Members Test
Components
Price 2600.0 AED
Sample Condition Blood
Report Delivery
Method
Test type
Doctor
Test Department:
Pre Test Information
Test Details

CLN6 is a gene associated with the rare genetic disorder, Ceroid Lipofuscinosis, Neuronal 6. This disorder primarily affects the nervous system and can lead to a range of symptoms including vision loss, seizures, movement difficulties, and cognitive decline.

When it comes to additional family members, it is important to consider the inheritance pattern of CLN6. This disorder is typically inherited in an autosomal recessive manner, meaning that both parents must carry a mutated copy of the CLN6 gene for their child to be affected.

If a person has CLN6 and they have siblings, there is a chance that their siblings could also be carriers of the mutated gene. If both parents are carriers, each sibling would have a 25% chance of being affected by CLN6, a 50% chance of being a carrier, and a 25% chance of not having the mutated gene at all.

It is recommended that family members of an individual with CLN6 consult with a genetic counselor or healthcare provider to understand their own risk and the potential implications for future family planning. Genetic testing can be performed to determine if someone is a carrier of the CLN6 mutation.